Trupanion Inc (NYSE:TRUP) received a $18.00 price target from equities researchers at RBC Capital Markets in a research note issued on Tuesday. The firm currently has a a “buy” rating on the stock. RBC Capital Markets’ price objective points to a potential upside of 7.53% from the company’s current price.
Several other equities analysts have also commented on TRUP. Lake Street Capital started coverage on shares of Trupanion in a research report on Tuesday, July 19th. They set a “buy” rating and a $18.00 price target for the company. Zacks Investment Research lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Wednesday, July 27th. Stifel Nicolaus upped their price target on shares of Trupanion from $17.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, August 3rd. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $19.00 price target on shares of Trupanion in a research report on Thursday, August 4th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $15.75.
Shares of Trupanion (NYSE:TRUP) opened at 16.74 on Tuesday. The firm’s market capitalization is $485.71 million. Trupanion has a one year low of $6.27 and a one year high of $17.68. The stock has a 50 day moving average of $15.37 and a 200-day moving average of $13.45.
Trupanion (NYSE:TRUP) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.06. The company had revenue of $45.83 million for the quarter, compared to analyst estimates of $45.05 million. During the same period last year, the company posted ($0.17) EPS. The business’s revenue for the quarter was up 28.8% on a year-over-year basis. On average, equities analysts anticipate that Trupanion will post ($0.22) earnings per share for the current fiscal year.
In other news, Director Howard E. Rubin sold 17,556 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $14.93, for a total value of $262,111.08. Following the completion of the transaction, the director now directly owns 162,399 shares in the company, valued at $2,424,617.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Howard E. Rubin sold 4,369 shares of the company’s stock in a transaction on Monday, August 22nd. The shares were sold at an average price of $14.94, for a total transaction of $65,272.86. Following the completion of the transaction, the director now owns 168,055 shares of the company’s stock, valued at $2,510,741.70. The disclosure for this sale can be found here.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Immersion Capital LLP purchased a new position in shares of Trupanion during the second quarter valued at $18,374,000. RMB Capital Management LLC purchased a new position in shares of Trupanion during the second quarter valued at $1,642,000. Hamilton Lane Advisors LLC purchased a new position in shares of Trupanion during the second quarter valued at $1,657,000. Grand Jean Capital Management Inc. increased its position in shares of Trupanion by 37.0% in the first quarter. Grand Jean Capital Management Inc. now owns 277,536 shares of the company’s stock valued at $2,734,000 after buying an additional 74,932 shares during the period. Finally, State Street Corp increased its position in shares of Trupanion by 50.5% in the second quarter. State Street Corp now owns 199,861 shares of the company’s stock valued at $2,650,000 after buying an additional 67,026 shares during the period.
Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.